Tenderwize
Back to tender search

Open House Discount Agreements for Bimatoprost

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline May 31, 2027 · 288 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Bimatoprost, ATC S01EE03

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

Buyer can terminate open-house contracts by awarding exclusive contracts through tenders during the contract period. Th...

No estimated value or framework maximum is provided, making it impossible to assess the commercial opportunity.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jul 2027
  • Conclusion of non-exclusive discount agreements for pharmaceutical products containing Bimatoprost (ATC S01EE03) under §§ 130a Abs. 8/130c Abs. 1 SGB V.
  • Contracts are open to all pharmaceutical companies during the period 01.08.2025 to 31.07.2027.
Show full summary

Non-exclusive discount agreements (open-house model) for Bimatoprost (ATC S01EE03) with AOK Rheinland-Pfalz/Saarland. The buyer offers uniform, non-negotiable contracts to all interested pharmaceutical companies. Contracts run up to 24 months, with earliest start 01.08.2025. This is not a public procurement but a voluntary transparency publication. No estimated value provided.

Risks

Buyer can terminate open-house contracts by awarding exclusive contracts through tenders during the contract period. Th...

No estimated value or framework maximum is provided, making it impossible to assess the commercial opportunity.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Tenderer must be a pharmaceutical company.
  • Products must be authorized and marketable in Germany.

Administrative

  • Submission of signed contract documents either in paper form (2 copies) with prior scan via email, or electronically with qualified electronic signature.

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Open House Discount Agreements for Bimatoprost

Open house model for non-exclusive discount agreements on Bimatoprost. All pharmaceutical companies can join under identical terms. Contracts are not exclusive; buyer reserves right to replace with exclusive contracts via tenders. Selection criteria: only authorized and marketable pharmaceuticals in Germany are eligible. Submission can be in writing (signed by hand, 2 copies) or electronically with qualified electronic signature.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Jul 2025 - Jul 2027

Category

Pharmaceutical products

Deadline

Deadline May 31, 2027

Procurement Details

Publication date
17 Jun 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
394745-2025

Documents (1)

Similar tenders